# Itovebi

NDC: 50242-079
Generic name: Inavolisib
Labeler / Manufacturer: Genentech, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20241014

FDA application: NDA219249

## Active ingredients

- INAVOLISIB: 9 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50242-079"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50242-079
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5de59f5b-e5db-410f-b692-658686ef4107